DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
EGANELISIB
2
Small molecule
Investigational
Unknown
Unknown
Unknown
PI3-kinase p110-gamma subunit inhibitor
EGANELISIB
×
Maximum Phase:
2
First Approval:
None
UNII:
FOF5155FMZ
Molecule Type:
Small molecule
Molecular Formula:
C30H24N8O2
Molecular Weight:
528.58
AlogP:
3.24
PSA:
125.13
HBD:
2.0
HBA:
#RotB:
4.0
Source:
DIHOMO-GAMMA-LINOLENIC ACID
2
Small molecule
Investigational
Unknown
Unknown
Dermatitis, Atopic
Unknown
DIHOMO-GAMMA-LINOLENIC ACID
×
Maximum Phase:
2
First Approval:
None
UNII:
FC398RK06S
Molecule Type:
Small molecule
Molecular Formula:
C20H34O2
Molecular Weight:
306.49
AlogP:
6.44
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
15.0
Source:
EPELSIBAN BESYLATE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
EPELSIBAN BESYLATE
×
Maximum Phase:
2
First Approval:
None
UNII:
H629P9T4UN
Molecule Type:
Small molecule
Molecular Formula:
C36H44N4O7S
Molecular Weight:
676.84
AlogP:
2.76
PSA:
91.84
HBD:
1.0
HBA:
#RotB:
6.0
Source:
AZD1446
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease; Attention Deficit Disorder with Hyperactivity
Neuronal acetylcholine receptor; alpha4/beta2 agonist
AZD1446
×
Maximum Phase:
2
First Approval:
None
UNII:
ANR9OP1V17
Molecule Type:
Small molecule
Molecular Formula:
C11H13ClN2O2
Molecular Weight:
240.69
AlogP:
1.22
PSA:
45.48
HBD:
1.0
HBA:
#RotB:
1.0
Source:
JBPOS-0101
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
JBPOS-0101
×
Maximum Phase:
2
First Approval:
None
UNII:
D7NM51C3GU
Molecule Type:
Small molecule
Molecular Formula:
C10H12ClNO3
Molecular Weight:
229.66
AlogP:
1.86
PSA:
72.55
HBD:
2.0
HBA:
#RotB:
3.0
Source:
PROFLAVINE
2
Small molecule
Investigational
Unknown
Unknown
Genital Neoplasms, Female; Barrett Esophagus; Carcinoma, Squamous Cell; Uterine Neoplasms
DNA disrupting agent
PROFLAVINE
×
Maximum Phase:
2
First Approval:
None
UNII:
CY3RNB3K4T
Molecule Type:
Small molecule
Molecular Formula:
C13H11N3
Molecular Weight:
209.25
AlogP:
2.55
PSA:
64.93
HBD:
2.0
HBA:
#RotB:
0.0
Source:
HYDROXYPROGESTERONE
2
Small molecule
Investigational
Unknown
Unknown
Premature Birth
Unknown
HYDROXYPROGESTERONE
×
Maximum Phase:
2
First Approval:
None
UNII:
21807M87J2
Molecule Type:
Small molecule
Molecular Formula:
C21H30O3
Molecular Weight:
330.47
AlogP:
3.84
PSA:
54.37
HBD:
1.0
HBA:
#RotB:
1.0
Source:
GSK-3117391
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid
Unknown
GSK-3117391
×
Maximum Phase:
2
First Approval:
None
UNII:
CKA3P0O1VI
Molecule Type:
Small molecule
Molecular Formula:
C22H33N3O4
Molecular Weight:
403.52
AlogP:
3.04
PSA:
100.55
HBD:
3.0
HBA:
#RotB:
9.0
Source:
MARALIXIBAT CHLORIDE
2
Small molecule
Investigational
Unknown
Unknown
Cholangitis, Sclerosing; Liver Cirrhosis, Biliary; Alagille Syndrome; Pruritus
Ileal bile acid transporter inhibitor
MARALIXIBAT CHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
V78M04F0XC
Molecule Type:
Small molecule
Molecular Formula:
C40H56ClN3O4S
Molecular Weight:
710.42
AlogP:
6.62
PSA:
70.08
HBD:
1.0
HBA:
#RotB:
13.0
Source:
BLZ945
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Amyotrophic Lateral Sclerosis
Unknown
BLZ945
×
Maximum Phase:
2
First Approval:
None
UNII:
7W3V82OQ0P
Molecule Type:
Small molecule
Molecular Formula:
C20H22N4O3S
Molecular Weight:
398.49
AlogP:
3.56
PSA:
96.37
HBD:
3.0
HBA:
#RotB:
5.0
Source:
HP184
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
HP184
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
REVAPRAZAN
2
Small molecule
Investigational
Unknown
Unknown
Gastroesophageal Reflux
Unknown
REVAPRAZAN
×
Maximum Phase:
2
First Approval:
None
UNII:
5P184180P5
Molecule Type:
Small molecule
Molecular Formula:
C22H23FN4
Molecular Weight:
362.45
AlogP:
5.1
PSA:
41.05
HBD:
1.0
HBA:
#RotB:
3.0
Source:
VB-201
2
Small molecule
Investigational
Unknown
Unknown
Colitis, Ulcerative; Psoriasis; Severe Acute Respiratory Syndrome
Monocyte differentiation antigen CD14 inhibitor
VB-201
×
Maximum Phase:
2
First Approval:
None
UNII:
SJ5A8151JO
Molecule Type:
Small molecule
Molecular Formula:
C29H60NO8P
Molecular Weight:
581.77
AlogP:
6.33
PSA:
114.35
HBD:
1.0
HBA:
#RotB:
30.0
Source:
CTS-1027
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis C; Hepatitis C, Chronic
Unknown
CTS-1027
×
Maximum Phase:
2
First Approval:
None
UNII:
2QD3F58224
Molecule Type:
Small molecule
Molecular Formula:
C19H20ClNO6S
Molecular Weight:
425.89
AlogP:
3.21
PSA:
101.93
HBD:
2.0
HBA:
#RotB:
6.0
Source:
TAK-448
2
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms; Hypogonadism
Unknown
TAK-448
×
Maximum Phase:
2
First Approval:
None
UNII:
YO029HR229
Molecule Type:
Small molecule
Molecular Formula:
C58H80N16O14
Molecular Weight:
1225.38
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
PRS-211375
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Cannabinoid CB2 receptor agonist
PRS-211375
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
9-AMINOCAMPTOTHECIN
2
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Esophageal Neoplasms; Kidney Neoplasms; Lung Neoplasms; Lymphoma; Ovarian Neoplasms; Peritoneal Neoplasms; Stomach Neoplasms
Unknown
9-AMINOCAMPTOTHECIN
×
Maximum Phase:
2
First Approval:
None
UNII:
5MB77ICE2Q
Molecule Type:
Small molecule
Molecular Formula:
C20H17N3O4
Molecular Weight:
363.37
AlogP:
1.66
PSA:
107.44
HBD:
2.0
HBA:
#RotB:
1.0
Source:
LUCANTHONE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LUCANTHONE
×
Maximum Phase:
2
First Approval:
None
UNII:
FC6D57000M
Molecule Type:
Small molecule
Molecular Formula:
C20H24N2OS
Molecular Weight:
340.49
AlogP:
4.48
PSA:
32.34
HBD:
1.0
HBA:
#RotB:
6.0
Source:
VESTIPITANT MESYLATE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Neurokinin 1 receptor antagonist
VESTIPITANT MESYLATE
×
Maximum Phase:
2
First Approval:
None
UNII:
OWR424W90Q
Molecule Type:
Small molecule
Molecular Formula:
C24H28F7N3O4S
Molecular Weight:
587.56
AlogP:
5.93
PSA:
35.58
HBD:
1.0
HBA:
#RotB:
3.0
Source:
BATEFENTEROL
2
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive
Beta-2 adrenergic receptor agonist
BATEFENTEROL
×
Maximum Phase:
2
First Approval:
None
UNII:
1IAT42T80T
Molecule Type:
Small molecule
Molecular Formula:
C40H42ClN5O7
Molecular Weight:
740.26
AlogP:
6.43
PSA:
165.25
HBD:
6.0
HBA:
#RotB:
13.0
Source:
GW-274150
2
Small molecule
Investigational
Unknown
Unknown
Asthma; Arthritis, Rheumatoid; Migraine Disorders
Nitric oxide synthase, inducible inhibitor
GW-274150
×
Maximum Phase:
2
First Approval:
None
UNII:
0ZZF1V8G63
Molecule Type:
Small molecule
Molecular Formula:
C8H17N3O2S
Molecular Weight:
219.31
AlogP:
0.11
PSA:
99.2
HBD:
4.0
HBA:
#RotB:
7.0
Source:
IBUDILAST
2
Small molecule
Investigational
Unknown
Unknown
Diabetic Neuropathies; Glioblastoma; Migraine Disorders; Pain; Substance-Related Disorders; Alcoholism; Amphetamine-Related Disorders; Amyotrophic Lateral Sclerosis; Multiple Sclerosis, Chronic Progressive; Opioid-Related Disorders; Pneumonia, Viral; Lung Diseases, Obstructive; Spinal Cord Diseases
Phosphodiesterase 10A inhibitor
IBUDILAST
×
Maximum Phase:
2
First Approval:
None
UNII:
M0TTH61XC5
Molecule Type:
Small molecule
Molecular Formula:
C14H18N2O
Molecular Weight:
230.31
AlogP:
3.3
PSA:
34.37
HBD:
0.0
HBA:
#RotB:
3.0
Source:
BATABULIN
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular
Unknown
BATABULIN
×
Maximum Phase:
2
First Approval:
None
UNII:
T4NP8G3K6Q
Molecule Type:
Small molecule
Molecular Formula:
C13H7F6NO3S
Molecular Weight:
371.26
AlogP:
3.33
PSA:
55.4
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ROGARATINIB
2
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Neoplasms; Urinary Bladder Neoplasms
Fibroblast growth factor receptor inhibitor
ROGARATINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
98BSN6N516
Molecule Type:
Small molecule
Molecular Formula:
C23H26N6O3S
Molecular Weight:
466.57
AlogP:
2.59
PSA:
107.01
HBD:
2.0
HBA:
#RotB:
6.0
Source:
IBEZAPOLSTAT
2
Small molecule
Investigational
Unknown
Unknown
Clostridium Infections
Unknown
IBEZAPOLSTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
5K543KNC5P
Molecule Type:
Small molecule
Molecular Formula:
C18H20Cl2N6O2
Molecular Weight:
423.3
AlogP:
2.37
PSA:
88.07
HBD:
2.0
HBA:
#RotB:
6.0
Source:
NS-2359
2
Small molecule
Investigational
Unknown
Unknown
Cocaine-Related Disorders; Attention Deficit Disorder with Hyperactivity; Depressive Disorder
Monoamine transporter inhibitor
NS-2359
×
Maximum Phase:
2
First Approval:
None
UNII:
76H76554PA
Molecule Type:
Small molecule
Molecular Formula:
C16H21Cl2NO
Molecular Weight:
314.26
AlogP:
4.21
PSA:
12.47
HBD:
0.0
HBA:
#RotB:
3.0
Source:
F18-FFNP
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
F18-FFNP
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FLUBENTYLOSIN
2
Small molecule
Investigational
Unknown
Unknown
Onchocerciasis
Unknown
FLUBENTYLOSIN
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C53H82FNO17
Molecular Weight:
1024.23
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
L-NAME
2
Small molecule
Investigational
Unknown
Unknown
Cardiovascular Diseases; Asthma
Unknown
L-NAME
×
Maximum Phase:
2
First Approval:
None
UNII:
V55S2QJN2X
Molecule Type:
Small molecule
Molecular Formula:
C7H15N5O4
Molecular Weight:
233.23
AlogP:
-1.43
PSA:
143.37
HBD:
4.0
HBA:
#RotB:
6.0
Source:
SONOLISIB
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Glioblastoma; Prostatic Neoplasms, Castration-Resistant
PI3-kinase class I inhibitor
SONOLISIB
×
Maximum Phase:
2
First Approval:
None
UNII:
987796874T
Molecule Type:
Small molecule
Molecular Formula:
C29H35NO8
Molecular Weight:
525.6
AlogP:
3.13
PSA:
119.44
HBD:
1.0
HBA:
#RotB:
8.0
Source:
CC-115
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Squamous Cell; Glioblastoma; Leukemia, Lymphocytic, Chronic, B-Cell; Neoplasm Metastasis; Osteosarcoma; Prostatic Neoplasms, Castration-Resistant
DNA-dependent protein kinase inhibitor
CC-115
×
Maximum Phase:
2
First Approval:
None
UNII:
FII75TFH5L
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MANITIMUS
2
Small molecule
Investigational
Unknown
Unknown
Graft vs Host Disease; Kidney Diseases
Unknown
MANITIMUS
×
Maximum Phase:
2
First Approval:
None
UNII:
4B135RK2KL
Molecule Type:
Small molecule
Molecular Formula:
C14H10F3N3O2
Molecular Weight:
309.25
AlogP:
3.28
PSA:
96.91
HBD:
2.0
HBA:
#RotB:
4.0
Source:
E7449
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
E7449
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PBF-680
2
Small molecule
Investigational
Unknown
Unknown
Asthma
Adenosine A1 receptor antagonist
PBF-680
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALAGEBRIUM
2
Small molecule
Investigational
Unknown
Unknown
Heart Failure, Diastolic
Unknown
ALAGEBRIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
DGH49JXB1F
Molecule Type:
Small molecule
Molecular Formula:
C13H14NOS+
Molecular Weight:
232.33
AlogP:
2.54
PSA:
20.95
HBD:
0.0
HBA:
#RotB:
3.0
Source:
1
2
…
123
124
125
126
127
128
129
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA